Gardner Lewis Asset Management’s Inozyme Pharma INZY Stock Holding History

Gardner Lewis Asset Management’s Portfolio INZY Stock Details INZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,257,765	Closed	-$5.03M	–	95
2025 Q2	$5.03M	Buy	+1,257,765	New	+$3.11M	1.26%	34

Gardner Lewis Asset Management's INZY Position: Q3 2025 in Review

Gardner Lewis Asset Management sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 1,257,765 shares — an estimated $5.03M sold.

Gardner Lewis Asset Management first reported a position in INZY in Q2 2025 and held it in 1 quarter. The position peaked at $5.03M in Q2 2025. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

Gardner Lewis Asset Management reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
Gardner Lewis Asset Management sold 1,257,765 Inozyme Pharma shares in Q3 2025, an estimated $5.03M.
Gardner Lewis Asset Management first reported a position in Inozyme Pharma in Q2 2025 and held it in 1 quarter.
Gardner Lewis Asset Management's Inozyme Pharma position peaked at $5.03M in Q2 2025.
0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on Gardner Lewis Asset Management's 13F filing for Q3 2025, filed 10 Nov 2025.